CanniMed Therapeutics Inc (TSE:CMED) insider Allan Mclay Fowler sold 31,777 shares of the stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of C$31.81, for a total transaction of C$1,010,826.37.
CanniMed Therapeutics Inc (TSE:CMED) traded up C$0.28 during trading on Monday, reaching C$35.58. 306,360 shares of the company were exchanged, compared to its average volume of 787,016. CanniMed Therapeutics Inc has a 12 month low of C$7.32 and a 12 month high of C$46.00. The stock has a market cap of $869.34 and a price-to-earnings ratio of -31.77.
About CanniMed Therapeutics
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.